Publications (84) María Aránzazu Tabernero Urbieta publications

filter_list

2024

  1. A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma

    Translational Research, Vol. 272, pp. 95-110

  2. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models

    Neuro-Oncology, Vol. 26, Núm. 7, pp. 1230-1246

2023

  1. Antiproliferative effect of boldine on neural progenitor cells and on glioblastoma cells

    Frontiers in Neuroscience, Vol. 17

2022

  1. Src: coordinating metabolism in cancer

    Oncogene, Vol. 41, Núm. 45, pp. 4917-4928

2021

  1. Efecto de la región de conexina43 inhibidora de Src en células madre de cáncer de pulmón

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 51

  2. Efecto del péptido antitumoral TAT-Cx43266-283 en células madre neurales en un modelo de glioma in vivo

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 84

  3. Erratum to “Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283” [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134 (EBioMedicine (2020) 62, (S2352396420305107), (10.1016/j.ebiom.2020.103134))

    EBioMedicine

  4. Erratum: Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo (Neuro-Oncology DOI: 10.1093/neuonc/noz243)

    Neuro-Oncology

  5. Impairment of autophagic flux participates in the antitumor effects of tat-cx43266-283 in glioblastoma stem cells

    Cancers, Vol. 13, Núm. 17

  6. Péptidos penetrantes para atacar al glioma y su microambiente

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 50

2020

  1. Christian Giaume (November 1951-July 2019)

    Glia, Vol. 68, Núm. 7, pp. 1321-1328

  2. Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo

    Neuro-Oncology, Vol. 22, Núm. 4, pp. 493-504

  3. Connexin43 region 266–283, via src inhibition, reduces neural progenitor cell proliferation promoted by egf and fgf-2 and increases astrocytic differentiation

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-22

  4. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283

    EBioMedicine, Vol. 62

2019

  1. Connexins in cancer: bridging the gap to the clinic

    Oncogene, Vol. 38, Núm. 23, pp. 4429-4451

2018

  1. An update on minding the gap in cancer

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1860, Núm. 1, pp. 237-243

  2. Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 65, Núm. 4, pp. 1109-1124

  3. Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis

    Cell Death and Disease, Vol. 9, Núm. 12

2017

  1. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK

    Stem Cell Reports, Vol. 9, Núm. 2, pp. 451-463

  2. A c-Src inhibitor peptide based on connexin43 exerts neuroprotective effects through the inhibition of glial hemichannel activity

    Frontiers in Molecular Neuroscience, Vol. 10